Text written in Basque and translated automatically by Elia without any subsequent editing. SEE ORIGINAL
Interview: Araitz Molano
In collaboration with the UPV-EHU, Progenika Biopharma has developed a chip that will help improve the diagnosis and prognosis of attention deficit hyperactivity disorder (ADHD).
Buletina
Bidali zure helbide elektronikoa eta jaso asteroko buletina zure sarrera-ontzian
Teknopolis
